Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02015208
Title Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre|Novartis
Age Groups: senior
Covered Countries CAN

No variant requirements are available.